AstraZeneca and BGT shelve experimental sepsis drug
Decision follows CytoFab’s poor mid-stage clinical trial results
Read MoreSection: Research
Icon to set up translational medicine centre in the UK
Expands early phase research presence at new Manchester site
Read More
End of the line for intravenous bapineuzumab in Alzheimer’s
Negative trial results for Pfizer and Johnson & Johnson to concede defeat
Read More
Novartis signs cancer immunotherapy deal with Penn
R&D alliance with the University of Pennsylvania will focus on novel T-cell immunotherapies
Read MoreAstellas to close US urology research facility
Work at Urogenix, North Carolina site will end by the end of the year
Read More